Safe Administration of Oxytocin

The Safe Administration of Oxytocin guideline report, developed by PCMCH in 2019, outlines best practice recommendations for the safe management of pregnant patients whose labour is induced or augmented with the medication oxytocin. The objective of the report is to reduce the risk of misuse and/or mismanagement of oxytocin by addressing risk factors that have contributed to common errors in its administration. To promote a culture of safety when using this high-alert medication, 11 best practice recommendations were identified and vetted by clinical experts.

To support implementation of these best practices recommendations, tools and an implementation toolkit have been created. This toolkit is intended to support hospitals in identifying which best practice recommendations to prioritize and implement. It aims to support implementation by providing tools that can be applied in practice, bridging identified gaps and enhancing safety when administering oxytocin.

Download the Safe Administration of Oxytocin – Implementation Toolkit.

Download the individual tools below.

Watch the Informational Video about the Safe Administration of Oxytocin Recommendations by clicking here.

Watch the March 7, 2022 Webinar on the Safe Administration of Oxytocin Guideline Report and Implementation Toolkit by clicking here.

In March, 2023, the Safe Administration of Oxytocin project was evaluated. Click here to learn more about the evaluation of this work.

Subscribe

Stay informed with Milestones, your source for clinical updates and resources in perinatal, newborn and child health. This newsletter is for healthcare providers and families across Ontario.